Cargando…

Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment

This study investigates the antidiabetic effects of salsalate on disease progression of diabetes in non-obese diabetic Goto-Kakizaki (GK) rats, an experimental model of type 2 diabetes. Salsalate was formulated in rat chow (1,000 ppm) and used to feed rats from 5 to 21 weeks of age. At 5 weeks of ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xi, DuBois, Debra C, Cao, Yanguang, Jusko, William J, Almon, Richard R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128793/
https://www.ncbi.nlm.nih.gov/pubmed/25120374
http://dx.doi.org/10.2147/DMSO.S65818
_version_ 1782330173918543872
author Wang, Xi
DuBois, Debra C
Cao, Yanguang
Jusko, William J
Almon, Richard R
author_facet Wang, Xi
DuBois, Debra C
Cao, Yanguang
Jusko, William J
Almon, Richard R
author_sort Wang, Xi
collection PubMed
description This study investigates the antidiabetic effects of salsalate on disease progression of diabetes in non-obese diabetic Goto-Kakizaki (GK) rats, an experimental model of type 2 diabetes. Salsalate was formulated in rat chow (1,000 ppm) and used to feed rats from 5 to 21 weeks of age. At 5 weeks of age, GK and Wistar (WIS) control rats were subdivided into four groups, each composed of six rats: GK rats with standard diet (GK-C); GK rats with salsalate-containing diet (GK-S); WIS rats with standard diet (WIS-C); and WIS rats with salsalate-containing diet (WIS-S). The GK-C rats (167.2±11.6 mg/dL) showed higher blood glucose concentrations than WIS-C rats (133.7±4.9 mg/dL, P<0.001) at the beginning of the experiment, and had substantially elevated blood glucose from an age of 15 weeks until sacrifice at 21 weeks (341.0±133.6 mg/dL). The GK-S rats showed an almost flat profile of blood glucose from 4 weeks (165.1±11.0 mg/dL) until sacrifice at 21 weeks of age (203.7±22.2 mg/dL). While this difference in blood glucose between 4 and 21 weeks in GK-S animals was significant, blood glucose at 21 weeks was significantly lower in GK-S compared to GK-C animals. At sacrifice, salsalate decreased plasma insulin (GK-S =1.0±0.3; GK-C =2.0±0.3 ng/mL, P<0.001) and increased plasma adiponectin concentrations (GK-S =15.9±0.7; GK-C =9.7±2.0 μg/mL, P<0.001). Salsalate also lowered total cholesterol in GK-S rats (96.1±8.5 mg/dL) compared with GK-C rats (128.0±11.4 mg/dL, P<0.001). Inflammation-related genes (Ifit1 and Iigp1) exhibited much higher mRNA expression in GK-C rats than WIS-C rats in liver, adipose, and muscle tissues, while salsalate decreased the Ifit1 and Iigp1 mRNA only in adipose tissue. These results suggest that salsalate acts to both increase adiponectin and decrease adipose tissue-based inflammation while preventing type 2 diabetes disease progression in GK rats.
format Online
Article
Text
id pubmed-4128793
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41287932014-08-12 Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment Wang, Xi DuBois, Debra C Cao, Yanguang Jusko, William J Almon, Richard R Diabetes Metab Syndr Obes Original Research This study investigates the antidiabetic effects of salsalate on disease progression of diabetes in non-obese diabetic Goto-Kakizaki (GK) rats, an experimental model of type 2 diabetes. Salsalate was formulated in rat chow (1,000 ppm) and used to feed rats from 5 to 21 weeks of age. At 5 weeks of age, GK and Wistar (WIS) control rats were subdivided into four groups, each composed of six rats: GK rats with standard diet (GK-C); GK rats with salsalate-containing diet (GK-S); WIS rats with standard diet (WIS-C); and WIS rats with salsalate-containing diet (WIS-S). The GK-C rats (167.2±11.6 mg/dL) showed higher blood glucose concentrations than WIS-C rats (133.7±4.9 mg/dL, P<0.001) at the beginning of the experiment, and had substantially elevated blood glucose from an age of 15 weeks until sacrifice at 21 weeks (341.0±133.6 mg/dL). The GK-S rats showed an almost flat profile of blood glucose from 4 weeks (165.1±11.0 mg/dL) until sacrifice at 21 weeks of age (203.7±22.2 mg/dL). While this difference in blood glucose between 4 and 21 weeks in GK-S animals was significant, blood glucose at 21 weeks was significantly lower in GK-S compared to GK-C animals. At sacrifice, salsalate decreased plasma insulin (GK-S =1.0±0.3; GK-C =2.0±0.3 ng/mL, P<0.001) and increased plasma adiponectin concentrations (GK-S =15.9±0.7; GK-C =9.7±2.0 μg/mL, P<0.001). Salsalate also lowered total cholesterol in GK-S rats (96.1±8.5 mg/dL) compared with GK-C rats (128.0±11.4 mg/dL, P<0.001). Inflammation-related genes (Ifit1 and Iigp1) exhibited much higher mRNA expression in GK-C rats than WIS-C rats in liver, adipose, and muscle tissues, while salsalate decreased the Ifit1 and Iigp1 mRNA only in adipose tissue. These results suggest that salsalate acts to both increase adiponectin and decrease adipose tissue-based inflammation while preventing type 2 diabetes disease progression in GK rats. Dove Medical Press 2014-08-01 /pmc/articles/PMC4128793/ /pubmed/25120374 http://dx.doi.org/10.2147/DMSO.S65818 Text en © 2014 Wang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Wang, Xi
DuBois, Debra C
Cao, Yanguang
Jusko, William J
Almon, Richard R
Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
title Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
title_full Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
title_fullStr Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
title_full_unstemmed Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
title_short Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
title_sort diabetes disease progression in goto-kakizaki rats: effects of salsalate treatment
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128793/
https://www.ncbi.nlm.nih.gov/pubmed/25120374
http://dx.doi.org/10.2147/DMSO.S65818
work_keys_str_mv AT wangxi diabetesdiseaseprogressioningotokakizakiratseffectsofsalsalatetreatment
AT duboisdebrac diabetesdiseaseprogressioningotokakizakiratseffectsofsalsalatetreatment
AT caoyanguang diabetesdiseaseprogressioningotokakizakiratseffectsofsalsalatetreatment
AT juskowilliamj diabetesdiseaseprogressioningotokakizakiratseffectsofsalsalatetreatment
AT almonrichardr diabetesdiseaseprogressioningotokakizakiratseffectsofsalsalatetreatment